Better understanding of Anti-schistosomal strategies through microarray analysis

Infectious Disorders - Drug Targets

Volumn 10, Issue 4, 2010, Pages 251-257

  Gobert, Geoffrey N ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Microarray; Praziquantel; Radiation Attenuation; Schistosome

Indexed keywords

ANTISCHISTOSOMAL AGENT; ARTEMETHER; PRAZIQUANTEL;

CHEMOTHERAPY; DETOXIFICATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOLOGY; MICROARRAY ANALYSIS; NONHUMAN; PARASITE; REVIEW; SCHISTOSOMA; SCHISTOSOMIASIS; VACCINATION;

EID: 77958539663     PISSN: 18715265     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152610791591601     Document Type: Review

References (66)

1. Doenhoff, M. J.; Cioli, D.; Utzinger, J. Praziquantel: mechanisms ofaction, resistance and new derivatives for schistosomiasis. Curr. Opin. Infect. Dis., 2008, 21(6), 659-667.
2. McManus, D. P.; Li, Y.; Gray, D. J.; Ross, A. G. Conquering 'snailfever': schistosomiasis and its control in China. Expert Rev. Anti. Infect. Ther., 2009, 7(4), 473-485.
3. Bickle, Q. D. Radiation-attenuated schistosome vaccination--a briefhistorical perspective. Parasitology, 2009, 136(12), 1621-1632.
4. Steinmann, P.; Keiser, J.; Bos, R.; Tanner, M.; Utzinger, J. Schistosomiasis and water resources development: systematicreview, meta-analysis, and estimates of people at risk. LancetInfect. Dis., 2006, 6(7), 411-425.
5. King, C. H.; Dickman, K.; Tisch, D. J. Reassessment of the cost ofchronic helminthic infection: a meta-analysis of disability-relatedoutcomes in endemic schistosomiasis. Lancet, 2005, 365(9470), 1561-1569.
6. Burke, M. L.; Jones, M. K.; Gobert, G. N.; Li, Y. S.; Ellis, M. K.; McManus, D. P. Immunopathogenesis of human schistosomiasis. Parasite Immunol., 2009, 31(4), 163-76.
7. Xiao, S.; Utzinger, J.; Chollet, J.; Endriss, Y.; N'Goran, E. K.; Tanner, M. Effect of artemether against Schistosoma haematobiumin experimentally infected hamsters. Int. J. Parasitol., 2000, 30(9), 1001-1016.
8. Xiao, S. H. Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins. Acta Trop., 2005, 96(2-3), 153-167.
9. Sabah, A. A.; Fletcher, C.; Webbe, G.; Doenhoff, M. J. Schistosoma mansoni: chemotherapy of infections of differentages. Exp. Parasitol., 1986, 61(3), 294-303.
10. Cioli, D.; Pica-Mattoccia, L. Praziquantel. Parasitol. Res., 2003, 90(Supp 1) S3-9.
11. Pica-Mattoccia, L.; Valle, C.; Basso, A.; Troiani, A. R.; Vigorosi, F.; Liberti, P.; Festucci, A.; Cioli, D. Cytochalasin D abolishes theschistosomicidal activity of praziquantel. Exp. Parasitol., 2007, 115(4), 344-351.
12. Kohn, A. B.; Roberts-Misterly, J. M.; Anderson, P. A.; Khan, N.; Greenberg, R. M. Specific sites in the Beta Interaction Domain of aschistosome Ca2+ channel beta subunit are key to its role insensitivity to the anti-schistosomal drug praziquantel. Parasitology, 2003, 127(Pt 4), 349-356.
13. Troiani, A. R.; Pica-Mattoccia, L.; Valle, C.; Cioli, D.; Mignogna, G.; Ronketti, F.; Todd, M. Is actin the praziquantel receptor? Int. J. Antimicrob. Agents, 2007, 30(3), 280-281.
14. Hu, W.; Yan, Q.; Shen, D. K.; Liu, F.; Zhu, Z. D.; Song, H. D.; Xu, X. R.; Wang, Z. J.; Rong, Y. P.; Zeng, L. C.; Wu, J.; Zhang, X.; Wang, J. J.; Xu, X. N.; Wang, S. Y.; Fu, G.; Zhang, X. L.; Wang, Z. Q.; Brindley, P. J.; McManus, D. P.; Xue, C. L.; Feng, Z.; Chen, Z.; Han, Z. G. Evolutionary and biomedical implications of aSchistosoma japonicum complementary DNA resource. Nat. Genet., 2003, 35(2), 139-147.
15. Verjovski-Almeida, S.; DeMarco, R.; Martins, E. A.; Guimaraes, P. E.; Ojopi, E. P.; Paquola, A. C.; Piazza, J. P.; Nishiyama, M. Y. Jr.; Kitajima, J. P.; Adamson, R. E.; Ashton, P. D.; Bonaldo, M. F.; Coulson, P. S.; Dillon, G. P.; Farias, L. P.; Gregorio, S. P.; Ho, P. L.; Leite, R. A.; Malaquias, L. C.; Marques, R. C.; Miyasato, P. A.; Nascimento, A. L.; Ohlweiler, F. P.; Reis, E. M.; Ribeiro, M. A.; Sa, R. G.; Stukart, G. C.; Soares, M. B.; Gargioni, C.; Kawano, T.; Rodrigues, V.; Madeira, A. M.; Wilson, R. A.; Menck, C. F.; Setubal, J. C.; Leite, L. C.; Dias-Neto, E. Transcriptome analysis ofthe acoelomate human parasite Schistosoma mansoni. Nat. Genet., 2003, 35(2), 148-157.
16. Fitzpatrick, J. M.; Johansen, M. V.; Johnston, D. A.; Dunne, D. W.; Hoffmann, K. F. Gender-associated gene expression in two relatedstrains of Schistosoma japonicum. Mol. Biochem. Parasitol., 2004, 136(2), 191-209.
17. Hoffmann, K. F.; Johnston, D. A.; Dunne, D. W. Identification ofSchistosoma mansoni gender-associated gene transcripts by cDNAmicroarray profiling. Genome Biol., 2002, 3(8), 41.
18. Fitzpatrick, J. M.; Johnston, D. A.; Williams, G. W.; Williams, D. J.; Freeman, T. C.; Dunne, D. W.; Hoffmann, K. F. An oligonucleotidemicroarray for transcriptome analysis of Schistosoma mansoni andits application/use to investigate gender-associated geneexpression. Mol. Biochem. Parasitol., 2005, 141(1), 1-13.
19. Gobert, G. N.; McInnes, R.; Moertel, L.; Nelson, C.; Jones, M. K.; Hu, W.; McManus, D. P. Transcriptomics tool for the humanSchistosoma blood flukes using microarray gene expressionprofiling. Exp. Parasitol., 2006, 114(3), 160-72.
20. Moertel, L.; Gobert, G. N.; McManus, D. P. Comparative real-timePCR and enzyme analysis of selected gender-associated moleculesin Schistosoma japonicum. Parasitology, 2008, 135(5), 575-83.
21. Moertel, L.; McManus, D. P.; Piva, T. J.; Young, L.; McInnes, R. L.; Gobert, G. N. Oligonucleotide microarray analysis of strain- andgender-associated gene expression in the human blood fluke,Schistosoma japonicum. Mol. Cell. Probes, 2006, 20(5), 280-289.
22. Vermeire, J. J.; Boyle, J. P.; Yoshino, T. P. Differential geneexpression and the effects of Biomphalaria glabrata embryonic(Bge) cell factors during larval Schistosoma mansoni development. Mol. Biochem. Parasitol. 2004, 135(1), 153-7.
23. Chai, M.; McManus, D. P.; McInnes, R.; Moertel, L.; Tran, M.; Loukas, A.; Jones, M. K.; Gobert, G. N. Transcriptome profiling oflung schistosomula, in vitro cultured schistosomula and adultSchistosoma japonicum. Cell. Mol. Life Sci., 2006, 63(7-8), 919-29.
24. Vermeire, J. J.; Taft, A. S.; Hoffmann, K. F.; Fitzpatrick, J. M.; Yoshino, T. P. Schistosoma mansoni: DNA microarray geneexpression profiling during the miracidium-to-mother sporocysttransformation. Mol. Biochem. Parasitol., 2006, 147(1), 39-47.
25. Dillon, G. P.; Feltwell, T.; Skelton, J. P.; Ashton, P. D.; Coulson, P. S.; Quail, M. A.; Nikolaidou-Katsaridou, N.; Wilson, R. A.; Ivens, A. C. Microarray analysis identifies genes preferentially expressedin the lung schistosomulum of Schistosoma mansoni. Int. J. Parasitol., 2006, 36(1), 1-8.
26. Gobert, G. N.; Moertel, L.; Brindley, P. J.; McManus, D. P. Developmental gene expression profiles of the human pathogenSchistosoma japonicum. BMC Genomics, 2009, 101, 28.
27. Jolly, E. R.; Chin, C. S.; Miller, S.; Bahgat, M. M.; Lim, K. C.; DeRisi, J.; McKerrow, J. H. Gene expression patterns duringadaptation of a helminth parasite to different environmental niches. Genome Biol., 2007, 8(4), R65.
28. Mutapi, F.; Mduluza, T.; Gomez-Escobar, N.; Gregory, W. F.; Fernandez, C.; Midzi, N.; Maizels, R. M. Immuno-epidemiology ofhuman Schistosoma haematobium infection: preferential IgG3antibody responsiveness to a recombinant antigen dependent onage and parasite burden. BMC Infect. Dis., 2006, 6, 96.
29. Rollinson, D. A wake up call for urinary schistosomiasis:reconciling research effort with public health importance. Parasitology, 2009, 136(12), 1593-610.
30. Liu, F.; Zhou, Y.; Wang, Z. Q.; Lu, G.; Zheng, H.; Brindley, P. J.; McManus, D. P.; Blair, D.; Zhang, Q. H.; Zhong, Y.; Wang, S.; Han, Z. G.; Chen, Z. The Schistosoma japonicum genome revealsfeatures of host-parasite interplay. Nature, 2009, 460(7253), 345-351.
31. Berriman, M.; Haas, B. J.; LoVerde, P. T.; Wilson, R. A.; Dillon, G. P.; Cerqueira, G. C.; Mashiyama, S. T.; Al-Lazikani, B.; Andrade, L. F.; Ashton, P. D.; Aslett, M. A.; Bartholomeu, D. C.; Blandin, G.; Caffrey, C. R.; Coghlan, A.; Coulson, R.; Day, T. A.; Delcher, A.; DeMarco, R.; Djikeng, A.; Eyre, T.; Gamble, J. A.; Ghedin, E.; Gu, Y.; Hertz-Fowler, C.; Hirai, H.; Hirai, Y.; Houston, R.; Ivens, A.; Johnston, D. A.; Lacerda, D.; Macedo, C. D.; McVeigh, P.; Ning, Z.; Oliveira, G.; Overington, J. P.; Parkhill, J.; Pertea, M.; Pierce, R. J.; Protasio, A. V.; Quail, M. A.; Rajandream, M. A.; Rogers, J.; Sajid, M.; Salzberg, S. L.; Stanke, M.; Tivey, A. R.; White, O.; Williams, D. L.; Wortman, J.; Wu, W.; Zamanian, M.; Zerlotini, A.; Fraser-Liggett, C. M.; Barrell, B. G.; El-Sayed, N. M. The genome of theblood fluke Schistosoma mansoni. Nature, 2009, 460(7253), 352-358.
32. Gunasekera, A. M.; Patankar, S.; Schug, J.; Eisen, G.; Wirth, D. F. Drug-induced alterations in gene expression of the asexual bloodforms of Plasmodium falciparum. Mol. Microbiol., 2003, 50(4), 1229-1239.
33. Natalang, O.; Bischoff, E.; Deplaine, G.; Proux, C.; Dillies, M. A.; Sismeiro, O.; Guigon, G.; Bonnefoy, S.; Patarapotikul, J.; Mercereau-Puijalon, O.; Coppee, J. Y.; David, P. H. Dynamic RNAprofiling in Plasmodium falciparum synchronized blood stagesexposed to lethal doses of artesunate. BMC Genomics, 2008, 9, 388.
34. Vande Waa, E. A.; Campbell, C. K.; O'Leary, K. A.; Tracy, J. W. Induction of Schistosoma mansoni glutathione S-transferase byxenobiotics. Arch. Biochem. Biophys., 1993, 303(1), 15-21.
35. Denninger, V.; Figarella, K.; Schonfeld, C.; Brems, S.; Busold, C.; Lang, F.; Hoheisel, J.; Duszenko, M. Troglitazone inducesdifferentiation in trypanosoma brucei. Exp. Cell Res., 2007, 313(9), 1805-19.
36. James, C. E.; Davey, M. W. Increased expression of ABC transportproteins is associated with ivermectin resistance in the modelnematode Caenorhabditis elegans. Int. J. Parasitol., 2009, 39(2), 213-220.
37. Correa Soares, J. B.; Menezes, D.; Vannier-Santos, M. A.; Ferreira-Pereira, A.; Almeida, G. T.; Venancio, T. M.; Verjovski-Almeida, S.; Zishiri, V. K.; Kuter, D.; Hunter, R.; Egan, T. J.; Oliveira, M. F. Interference with hemozoin formation represents an importantmechanism of schistosomicidal action of antimalarial quinolinemethanols. PLoS Negl. Trop. Dis., 2009, 3(7), e477.
38. Aragon, A. D.; Imani, R. A.; Blackburn, V. R.; Cupit, P. M.; Melman, S. D.; Goronga, T.; Webb, T.; Loker, E. S.; Cunningham, C. Towards an understanding of the mechanism of action ofpraziquantel. Mol. Biochem. Parasitol., 2009, 164(1), 57-65.
39. Aragon, A. D.; Imani, R. A.; Blackburn, V. R.; Cunningham, C. Microarray based analysis of temperature and oxidative stressinduced messenger RNA in Schistosoma mansoni. Mol. Biochem. Parasitol., 2008, 162(2), 134-141.
40. Gobert, G. N.; Jones, M. K. Discovering new schistosome drugtargets: the role of transcriptomics. Curr. Drug Targets, 2008, 9(11), 922-930.
41. Brindley, P. J.; Sher, A. The chemotherapeutic effect ofpraziquantel against Schistosoma mansoni is dependent on hostantibody response. J. Immunol., 1987, 139(1), 215-220.
42. Ribeiro, F.; Mello, R. T.; Tavares, C. A.; Kusel, J. R.; Coelho, P. M. Synergistic action of praziquantel and host specific immuneresponse against Schistosoma mansoni at different phases ofinfection. Rev. Inst. Med. Trop. Sao Paulo, 2004, 46(4), 231-233.
43. Zhang, Y.; Koukounari, A.; Kabatereine, N.; Fleming, F.; Kazibwe, F.; Tukahebwa, E.; Stothard, J. R.; Webster, J. P.; Fenwick, A. Parasitological impact of 2-year preventive chemotherapy onschistosomiasis and soil-transmitted helminthiasis in Uganda. BMCMed., 2007, 5, 27.
44. Cioli, D.; Botros, S. S.; Wheatcroft-Francklow, K.; Mbaye, A.; Southgate, V.; Tchuente, L. A.; Pica-Mattoccia, L.; Troiani, A. R.; El-Din, S. H.; Sabra, A. N.; Albin, J.; Engels, D.; Doenhoff, M. J. Determination of ED50 values for praziquantel in praziquantelresistantand -susceptible Schistosoma mansoni isolates. Int. J. Parasitol., 2004, 34(8), 979-987.
45. Gryseels, B.; Mbaye, A.; De Vlas, S. J.; Stelma, F. F.; Guisse, F.; Van Lieshout, L.; Faye, D.; Diop, M.; Ly, A.; Tchuem-Tchuente, L. A.; Engels, D.; Polman, K. Are poor responses to praziquantelfor the treatment of Schistosoma mansoni infections in Senegal dueto resistance? An overview of the evidence. Trop. Med. Int. Health, 2001, 6(11), 864-873.
46. Ismail, M.; Botros, S.; Metwally, A.; William, S.; Farghally, A.; Tao, L. F.; Day, T. A.; Bennett, J. L. Resistance to praziquantel:direct evidence from Schistosoma mansoni isolated from Egyptianvillagers. Am. J. Trop. Med. Hyg. 1999, 60(6), 932-935.
47. Geerts, S.; Gryseels, B. Anthelmintic resistance in humanhelminths: a review. Trop. Med. Int. Health, 2001, 6(11), 915-921.
48. Pica-Mattoccia, L.; Doenhoff, M. J.; Valle, C.; Basso, A.; Troiani, A. R.; Liberti, P.; Festucci, A.; Guidi, A.; Cioli, D. Genetic analysisof decreased praziquantel sensitivity in a laboratory strain ofSchistosoma mansoni. Acta Trop., 2009, 111(1), 82-85.
49. Sato, H.; Kusel, J. R.; Thornhill, J. Excretion of fluorescentsubstrates of mammalian multidrug resistance-associated protein(MRP) in the Schistosoma mansoni excretory system. Parasitoloy, 2004, 128(Pt 1), 43-52.
50. James, C. E.; Hudson, A. L.; Davey, M. W. Drug resistancemechanisms in helminths: is it survival of the fittest? TrendsParasitol., 2009, 25(7), 328-335.
51. Siddiqui, A. A.; Ahmad, G.; Damian, R. T.; Kennedy, R. C. Experimental vaccines in animal models for schistosomiasis. Parasitol. Res., 2008, 102(5), 825-33.
52. Jones, M. K.; Lustigman, S.; Loukas, A. Tracking the odysseys ofjuvenile schistosomes to understand host interactions. PLoS Negl. Trop. Dis., 2008, 2(7), e257.
53. Dillon, G. P.; Feltwell, T.; Skelton, J.; Coulson, P. S.; Wilson, R. A.; Ivens, A. C. Altered patterns of gene expression underlying theenhanced immunogenicity of radiation-attenuated schistosomes. PLoS Negl. Trop. Dis., 2008, 2(5), e240.
54. Wilson, R. A. The saga of schistosome migration and attrition. Parasitology, 2009, 136(12), 1581-1592.
55. Gui, M.; Kusel, J. R.; Shi, Y. E.; Ruppel, A. Schistosoma japonicumand S. mansoni: comparison of larval migration patterns in mice. J. Helminthol., 1995, 69(1), 19-25.
56. Cardoso, F. C.; Macedo, G. C.; Gava, E.; Kitten, G. T.; Mati, V. L.; de Melo, A. L.; Caliari, M. V.; Almeida, G. T.; Venancio, T. M.; Verjovski-Almeida, S.; Oliveira, S. C. Schistosoma mansoniTegument Protein Sm29 Is Able to Induce a Th1-Type of ImmuneResponse and Protection against Parasite Infection. PLoS Negl. Trop. Dis., 2008, 2(10), e308.
57. Yang, W.; Gobert, G. N.; McManus, D. P. Oral vaccination of micewith recombinant Schistosoma japonicum proteins induces specificanti-parasite antibodies and damage to adult worms after achallenge infection. Int. J. Parasitol., 1997, 27(7), 843-853.
58. Gobert, G. N.; Moertel, L. P.; McManus, D. P. Microarrays: newtools to unravel parasite transcriptomes. Parasitology, 2005, 131(Pt 4), 439-448.
59. Correnti, J. M.; Brindley, P. J.; Pearce, E. J. Long-term suppressionof cathepsin B levels by RNA interference retards schistosomegrowth. Mol. Biochem. Parasitol., 2005, 143(2), 209-215.
60. Mann, V. H.; Morales, M. E.; Rinaldi, G.; Brindley, P. J. Culture forgenetic manipulation of developmental stages of Schistosomamansoni. Parasitology, 2009, 137(3), 451-462.
61. Morales, M. E.; Rinaldi, G.; Gobert, G. N.; Kines, K. J.; Tort, J. F.; Brindley, P. J. RNA interference of Schistosoma mansoni cathepsinD, the apical enzyme of the hemoglobin proteolysis cascade. Mol. Biochem. Parasitol, 2008, 157(2), 160-168.
62. Faghiri, Z.; Skelly, P. J. The role of tegumental aquaporin from thehuman parasitic worm, Schistosoma mansoni, in osmoregulationand drug uptake. FASEB J., 2009, 23(8), 2780-2789.
63. Krautz-Peterson, G.; Bhardwaj, R.; Faghiri, Z.; Tararam, C. A.; Skelly, P. J. RNA interference in schistosomes: machinery andmethodology. Parasitology, 2009, 1-11.
64. Rinaldi, G.; Morales, M. E.; Alrefaei, Y. N.; Cancela, M.; Castillo, E.; Dalton, J. P.; Tort, J. F.; Brindley, P. J. RNA interferencetargeting leucine aminopeptidase blocks hatching of Schistosomamansoni eggs. Mol. Biochem. Parasitol., 2009, 167(2), 118-126.
65. Torres, T. T.; Metta, M.; Ottenwalder, B.; Schlotterer, C. Geneexpression profiling by massively parallel sequencing. GenomeRes., 2008, 18(1), 172-177.
66. Liu, F.; Jenssen, T. K.; Trimarchi, J.; Punzo, C.; Cepko, C. L.; Ohno-Machado, L.; Hovig, E.; Kuo, W. P. Comparison of hybridization-based and sequencing-based gene expression technologieson biological replicates. BMC Genomics, 2007, 8, 153.